Ability to detect cognitive impairments through various neuropsychological tests in patients with type 2 diabetes mellitus

Authors

  • Zherdova N. N. P. L. Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine
  • Mankovsky B. N. P. L. Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine

DOI:

https://doi.org/10.21856/j-PEP.2018.1.03

Keywords:

diabetes mellitus, neuropsychometric tests, memory

Abstract

The article provides data on the diagnostic value of various neuropsychological tests for detecting cogni­tive deficits in patients with type 2 diabetes mellitus. The study included 101 patients with type 2 diabetes. The state of cognitive functions was determined using standard psychoneurometric tests adjusted for age and educational level. It has been found that for the screening of cognitive impairments in patients with type 2 dia­betes, it is best to use the TMT and Stroop Test as having a high incidence of cognitive impairment.

References

Kodl CT, Seaquist ER. Endocrine Rev 2008; 29(4): 494-511. doi: http://doi.org/10.1210/er.2007-0034

Jacobson AM, Musen G, Ryan CM, et al. N Engl J Med 2007; 356:1842-1852. doi: http://doi.org/10.1056/NEJMbkrev57613

Cox DJ, Kovatchev BP, Gonder-Frederick LA, et al. Diabetes Care 2005; 28:71-77. doi: http://doi.org/10.2337/diacare.28.1.71

Ott A, Stolk RP, van Harskamp F, et al. Neurology. 1999; 53(9):1937-1942. doi: http://doi.org/10.1212/WNL.53.9.1937

Ohara T, Doi Y, Ninomiya T, et al. Neurology. 2011;77(12):1126-1134. doi: http://doi.org/10.1212/WNL.0b013e31822f0435

Pasquier F. Metabolism 2010; 36:100-105.

Alencar RC, Cobas RA, Gomez MB. Diabetol Metab Syndr 2010; 2:1-6. doi: http://doi.org/10.1186/1758-5996-2-4

Pasquier F. J Neurol 1999; 246:6-15. doi: http://doi.org/10.1007/s004150050299

Sinelair AJ, Girling AJ, Bayer AJ. Diabetes Res Clin Pract 2000; 50:203-212. doi: http://doi.org/10.1016/S0168-8227(00)00195-9

Pangman VC, Sloan J, Guse L. Appl Nurs Res 2000;13(4):209-213. doi: http://doi.org/10.1053/apnr.2000.9231

Dubois B, Slachevsky A, Litvan I., et al. Neurology 2000; 5:1621-1626. doi: http://doi.org/10.1212/WNL.55.11.1621

Dubois B, Touchon J, Portet F, et al. Presse Med 2002;31:1696-1699.

Lezak M. Neuropsychological Assessment. Oxford, 2012:1200 p.

Schoenberg MR, Dawsonb KA, Duff K, et al. Arch Clin Neuropsychol 2006; 21:693-703. doi: http://doi.org/10.1016/j.acn.2006.06.006

Atkinson TM, Ryan JP. J Psychoeducat Ass 2008;26:42-53. doi: http://doi.org/10.1177/0734282907301592

Bor D, Owen, AM. Cerebral Cortex 2007; 17:778-786. doi: http://doi.org/10.1093/cercor/bhk035

Owen, AM, Lee AC, Williams EJ. Psychobiology 2000;28(2):146-155.

Lehmann V, Makine C, Karşıdağ C, et al. BMC Med Res Methodol 2011; 11:109.doi: http://doi.org/10.1186/1471-2288-11-109

Hommel B, Ridderinkhof R, Theeuwes J. Psychol Res 2002; 66(4):215-219. doi: http://doi.org/10.1007/s00426-002-0100-y

Agrell B, Dehljn O. Age and Ageing 1998; 27:399-403.doi: http://doi.org/10.1093/ageing/27.3.399

Exalto LG, Biessels GJ, Karter AJ, et al. Lancet Diabetes Endocrinol 2013; 1:183-190. doi: http://doi.org/10.1016/S2213-8587(13)70048-2

Biessels GJ, Strachan MW, Visseren FL, et al. Lancet Diabetes Endocrinol 2014; 2:246-255.doi: http://doi.org/10.1016/S2213-8587(13)70088-3

Downloads

Published

2021-06-30

How to Cite

Zherdova, N. N. ., & Mankovsky, B. N. . (2021). Ability to detect cognitive impairments through various neuropsychological tests in patients with type 2 diabetes mellitus. Problems of Endocrine Pathology, 63(1), 22-28. https://doi.org/10.21856/j-PEP.2018.1.03

Issue

Section

CLINICAL ENDOCRINOLOGY